Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.10.0.1
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets    
Cash and cash equivalents $ 1,291 $ 161,215
Prepaid expenses 11,792 11,458
Total current assets 13,083 172,673
TOTAL ASSETS 13,083 172,673
Current Liabilities    
Accounts payable 847,750 735,051
Accrued expenses 1,241,232 582,236
Note payable 49,900 48,000
Convertible loan notes, net 345,640 57,796
Derivative liability 1,502,000 930,000
Settlement payable 17,000 20,000
Interest payable 42,660 15,232
Total Current Liabilities 4,046,182 2,388,315
Long Term Liabilities    
Notes Payable 100,000 0
Total Long Term Liabilities 100,000 0
TOTAL LIABILITIES 4,146,182 2,388,315
Commitments and contingencies (see note 9)
Stockholders' (Deficit) Equity    
Preferred stock: 50,000,000 authorized; $0.0001 par value 0 shares issued and outstanding 0 0
Preferred stock Series A: 5,000,000 authorized; $0.0001 par value 4,558,042 shares issued and 0 shares outstanding 0 0
Preferred stock Series B-1: 32,000,000 authorized; $0.0001 par value 2,800,000 issued and outstanding 280 280
Preferred stock Series B-2: 10,000,000 authorized; $0.0001 par value 8,684,000 shares issued and outstanding, respectively 868 868
Preferred stock Series C: 1,733,334 authorized; $0.0001 par value 1,733,334 shares issued and outstanding 173 173
Preferred stock Series D: 200 authorized; $0.0001 par value 45 and 0 shares issued and outstanding, respectively 1 0
Common stock: 200,000,000 shares authorized; $0.0001 par value 39,775,689 and 35,071,862 shares issued and outstanding, respectively 3,977 3,507
Additional paid-in capital 5,291,002 3,980,103
Accumulated deficit (9,429,400) (6,200,573)
Total Stockholders' (Deficit) Equity (4,133,099) (2,215,642)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 13,083 $ 172,673